Volume 6, Issue 1 Supplement, October 2011

PROCEEDINGS 112th National Congress of the Italian Society of Internal Medicine Rome, 22-25 October 2011

ISSN: 1828-0447 (Print) 1970-9366 (Online)

In this issue (21 articles)

previous disabled Page of 2
  1. Acknowledgement to Referees

    Acknowledgement to Referees

    Article:139
  2. No Access

    SELECTED PAPERS - SUBCLINICAL RENAL INSUFFICIENCY

    Management of patients with chronic kidney disease

    Francesco P. Schena Article:77
  3. No Access

    SELECTED PAPERS - SUBCLINICAL RENAL INSUFFICIENCY

    Chronic kidney disease epidemic: myth and reality

    Filippo Mangione, Antonio Dal Canton Article:69
  4. No Access

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK

    Residual cardiovascular risk in secondary prevention

    Alberto Zambon Article:61
  5. No Access

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK

    What intervention trials don’t tell us: the residual risk in primary prevention

    Claudio Cimminiello Article:53
  6. No Access

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK

    The epidemiological concept of residual risk

    Diego Vanuzzo Article:45
  7. No Access

    SYMPOSIUM – METABOLIC THERAPY: NEW OPPORTUNITY FOR TREATMENT OF HEART FAILURE

    Effects of supplementation with polyunsaturated fatty acids in patients with heart failure

    Savina Nodari, Marco Triggiani, Alessandra Manerba Article:37
  8. No Access

    SYMPOSIUM – METABOLIC THERAPY: NEW OPPORTUNITY FOR TREATMENT OF HEARTH FAILURE

    Salt and water imbalance in chronic heart failure

    Gaspare Parrinello, Daniele Torres, Salvatore Paterna Article:29
  9. No Access

    SYMPOSIUM – BIOLOGICAL THERAPIES: NEW INDICATIONS, CLINICAL AND PHARMACO-ECONOMIC ASSESSMENT

    Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease

    Antonio Di Sabatino, Lucio Liberato, Monia Marchetti Article:17
  10. No Access

    SYMPOSIUM – BIOLOGICAL THERAPIES: NEW INDICATIONS, CLINICAL AND PHARMACO-ECONOMIC ASSESSMENT

    Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)

    Gianfranco Ferraccioli, Elisa Gremese Article:11
previous disabled Page of 2